{"filing":{"accession_number":"0001829126-26-007475","cik":"0002091712","ticker":"RFAMU","company_name":"RF Acquisition Corp III","form":"8-K","filing_date":"2026-07-09","report_date":null,"primary_document":"rfacquisition3_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2091712/000182912626007475/rfacquisition3_8k.htm"},"events":[{"id":16917,"run_id":15143,"accession_number":"0001829126-26-007475","anchor_item_number":"1.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"summary":"RF Acquisition Corp III entered into a Business Combination Agreement with HCC Healthcare on July 9, 2026, whereby HCC Healthcare will become a publicly traded company on Nasdaq with an approximately $500 million equity valuation, with closing expected in Q4 2026.","company_name":"RF Acquisition Corp III","ticker":"RFAMU","filing_date":"2026-07-09","form":"8-K","submitted_at":null,"items":[{"id":15165,"accession_number":"0001829126-26-007475","item_number":"1.01","item_title":"Entry Into A Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"RF Acquisition Corp III entered into a Business Combination Agreement with HCC Healthcare on July 9, 2026, providing for a merger whereby HCC Healthcare will become a publicly traded company on Nasdaq with an approximately $500 million equity valuation. This is a material acquisition/change of control transaction disclosed under Item 1.01, involving the entry into a definitive agreement for a business combination that will result in HCC Healthcare becoming the surviving entity and RF Acquisition merging into a subsidiary thereof.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T10:54:13.706276+00:00","company_name":"","ticker":null,"filing_date":""},{"id":15166,"accession_number":"0001829126-26-007475","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"RF Acquisition Corp III and HCC Healthcare executed a Business Combination Agreement on July 9, 2026, with HCC Healthcare expected to become a publicly traded company upon closing. The transaction reflects a pre-transaction equity value of approximately US$500 million and is expected to close in Q4 2026. This is a material M\u0026A activity—specifically a SPAC merger/change of control—disclosed via joint press release under Item 7.01 (Regulation FD Disclosure).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T10:54:13.706276+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":15165,"accession_number":"0001829126-26-007475","item_number":"1.01","item_title":"Entry Into A Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"RF Acquisition Corp III entered into a Business Combination Agreement with HCC Healthcare on July 9, 2026, providing for a merger whereby HCC Healthcare will become a publicly traded company on Nasdaq with an approximately $500 million equity valuation. This is a material acquisition/change of control transaction disclosed under Item 1.01, involving the entry into a definitive agreement for a business combination that will result in HCC Healthcare becoming the surviving entity and RF Acquisition merging into a subsidiary thereof.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T10:54:13.706276+00:00","company_name":"RF Acquisition Corp III","ticker":"RFAMU","filing_date":"2026-07-09"},{"id":15166,"accession_number":"0001829126-26-007475","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"RF Acquisition Corp III and HCC Healthcare executed a Business Combination Agreement on July 9, 2026, with HCC Healthcare expected to become a publicly traded company upon closing. The transaction reflects a pre-transaction equity value of approximately US$500 million and is expected to close in Q4 2026. This is a material M\u0026A activity—specifically a SPAC merger/change of control—disclosed via joint press release under Item 7.01 (Regulation FD Disclosure).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T10:54:13.706276+00:00","company_name":"RF Acquisition Corp III","ticker":"RFAMU","filing_date":"2026-07-09"}]}